alpha-v/beta-6 integrin inhibitor (Encodia/University of Washington/Children's Medical Center/Brigham Young University/Harvard Medical School)

N/A

Report date: 2025/03/14 16:27:14

Base Information

Drug Namealpha-v/beta-6 integrin inhibitor (Encodia/University of Washington/Children's Medical Center/Brigham Young University/Harvard Medical School)
Drug Alias NameBP2-disulf
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin alpha-V/beta-6 inhibitors
TargetsIntegrin alpha-V/beta-6
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A